News
Investing.com -- Shares of Penumbra (NYSE:PEN) rose by 5% following comments from Piper Sandler analyst Matt O’Brien, who indicated that the medical device company’s Thunderbolt product might ...
Penumbra, Inc. (NYSE:PEN) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating expectations ...
Guidance: Penumbra reaffirms its fiscal year 202 sales guidance of $1.34 billion to $1.36 billion, versus the consensus of $1.35 billion. The company is increasing guidance for the U.S ...
To record the event, the VTF relied on sunlight with a wavelength of 588.9 nanometers, and also depicts the sunspot’s penumbra over a region measuring approximately 15,535-square-miles.
Penumbra Inc. (PEN), a medical devices company with a market capitalization of $10.78 billion, reported robust financial results for the first quarter of 2025, surpassing expectations and sending ...
The world's largest solar telescope, the U.S. National Science Foundation (NSF ... It shows a dark sunspot with its finely structured penumbra in a section of the solar surface measuring ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Wednesday reported first-quarter net income of $39.2 million. On a per-share basis, the Alameda, California-based company ...
The Moon’s umbra — the darkest part of its shadow — did not reach Earth. Instead, it was the penumbra, the lighter outer shadow, that was projected over the visible areas of the eclipse: the North ...
As a result, observers in the path of the penumbra (the outer shadow of the Moon) will see the Sun appear as though a “bite” has been taken out of it. The first solar eclipse of 2025 will ...
The final leg of its journey, through the penumbra, finishes at 6:01 a.m. Although ... Katrina Miller is a science reporter for The Times based in Chicago. She earned a Ph.D. in physics from ...
Penumbra's shares have surged again on renewed confidence in mechanical thrombectomy growth and a competitor's acquisition, but the current valuation is high at over 7x 2025 revenue estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results